HOME >> BIOLOGY >> NEWS
Scientific issues associated with carbon-neutral energy sources such as cellulosic ethanol

Boston -- Professor Chris Somerville of the Carnegie Institution and Stanford University, explained advances in plant science research that are both needed and achievable to reduce costs and multiply current levels of production of biofuels from plant cellulose (biomass).

Somerville presented his talk, "Bioenergy: The 21st Century Challenge to Plant Biologists" at the Annual Meeting of the American Society of Plant Biologists (ASPB) today (4:30 p.m. Eastern Time August 5) in Boston's Hynes Convention Center. The presentation was part of the Major Symposium: "Plants Mitigating Global Change" organized by Professor Stephen Long of the University of Illinois at Urbana-Champaign.

Somerville noted the concept that CO2 emissions may negatively affect climate are not new.

"In 1895, Arrhenius presented a paper to the Stockholm Physical Society titled, On the Influence of Carbonic Acid in the Air upon the Temperature of the Ground in which he argued that increased concentration of atmospheric CO2, such as that caused by combustion of fossil fuel, would lead to the warming of the earth," Somerville commented. "It is apparent that he [Arrhenius] was correct and that we must develop alternative sources of energy."

The earth receives approximately 4,000 times more energy from the sun each year than the total projected human uses in the year 2050, Somerville commented. Green plants growing throughout the world capture the sun's (solar) energy and convert it to bio-chemical energy in a process called photosynthesis. There are vast energy supplies of renewable plant biomass growing throughout the nation and world. There is widespread interest in returning to the use of plants as widely used sources of renewable energy

.

"However, because of competing uses for land, a central challenge for 21st century biologists is to increase the efficiency of solar energy capture to the theoretical limit by rational methods. In order to acc
'"/>

Contact: Brian Hyps
bhyps@aspb.org
310-251-0560
American Society of Plant Biologists
5-Aug-2006


Page: 1 2

Related biology news :

1. Scientific American launches innovative new version of magazine
2. International Society for Heart and Lung Transplantation 27th Annual Meeting and Scientific Sessions
3. Scientific literacy happens -- when students think for themselves
4. AAAS honors defenders of evolution with Scientific Freedom and Responsibility Award
5. 2006 AAAS International Scientific Cooperation Award goes to Arizona State U. landscape ecologist
6. A Cross-Disciplinary Look at Scientific Truth: Whats the Law to Do?
7. Scientific meeting on pulmonary hypertension, December 7-8
8. Scientific American names UCSB professor, alumna to list of Top 50 in Technological Leadership
9. Two Pitt researchers make Scientific American 50 of leaders in science and technology
10. Stevens and Monmouth Presidents to co-chair ASBPA National Scientific Shore and Beach Conference
11. Scientific group endorses radical plan to save rainforests

Post Your Comments:
(Date:7/23/2014)... Chrysomya megacephala is commonly found in dead bodies ... time of death, referred to as the post mortem ... C. megacephala from Tamil Nadu is provided for ... characterization through generation of DNA barcoding. This study, significant ... Biodiversity Data Journal . , Chrysomya megacephala ...
(Date:7/23/2014)... New Rochelle, NY -- The potential for clinical ... for transplant-based therapeutic strategies has previously been hindered ... the development of tumors. The ability to use ... for the treatment of heart disease, specifically acute ... Stem Cells and Development , a peer-reviewed ...
(Date:7/23/2014)... MINNETONKA, Minn. , July 23, 2014 /PRNewswire/ ... technology company specializing in clinical study management systems, ... West , a proven life sciences industry executive ... named Chief Operating Officer (COO).  Clareece will be ... and sales growth, operational efficiency and quality product/service ...
Breaking Biology News(10 mins):Dead body feeding larvae useful in forensic investigations 2MedNet Appoints Clareece West As Chief Operating Officer 2
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... regulated information -- UCB today announced an important advance ... topline results from the latest Phase 3 study ... evaluate the efficacy and safety of brivaracetam ... to placebo, as adjunctive treatment in adult focal ... despite treatment with one or two concomitant antiepileptic ...
(Date:7/23/2014)... 2014  Sofinnova Ventures, a Menlo Park ... of Sofinnova Venture Partners IX, L.P. at the hard ... initial fund target of $425 million. Sofinnova ... Consistent with recent funds, SVP IX will provide capital ... along with select investments in earlier stage opportunities. Investments ...
(Date:7/23/2014)... 2014 OncLive® is pleased to ... joined its Strategic Alliance Partnership program. , ... UNC Lineberger will have the opportunity to work ... its cutting-edge research initiatives, community-directed cancer prevention programs, ... work with OncLive to educate their peers by ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
Cached News: